193 related articles for article (PubMed ID: 15369140)
1. Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Shimizu N; Orita K
Hum Cell; 2004 Jun; 17(2):85-92. PubMed ID: 15369140
[TBL] [Abstract][Full Text] [Related]
2. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
Matsuo Y; Drexler HG
Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor expression in B-cell precursor-leukemia cell lines: preferential expression of T-bet.
Harashima A; Matsuo Y; Drexler HG; Okochi A; Motoda R; Tanimoto M; Orita K
Leuk Res; 2005 Jul; 29(7):841-8. PubMed ID: 15927679
[TBL] [Abstract][Full Text] [Related]
4. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
Drexler HG; Matsuo Y
Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
[TBL] [Abstract][Full Text] [Related]
5. Induced natural killer-like cytotoxic function in the TCR delta-1 positive human leukemic T-cell lines.
Ariyasu T; Kimura N; Kikuchi M; Kohno K; Sugamura K; Watanabe T; Minowada J
Leukemia; 1991 Sep; 5(9):807-12. PubMed ID: 1834894
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of human B cell precursor-leukemia cell lines.
Matsuo Y; Drexler HG
Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
[TBL] [Abstract][Full Text] [Related]
8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
9. Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas.
Lin CW; Lee WH; Chang CL; Yang JY; Hsu SM
Am J Pathol; 2001 Nov; 159(5):1671-9. PubMed ID: 11696428
[TBL] [Abstract][Full Text] [Related]
10. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
11. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
[TBL] [Abstract][Full Text] [Related]
12. Human CD3-CD16+ natural killer cells express the hGATA-3 T cell transcription factor and an unrearranged 2.3-kb TcR delta transcript.
Biassoni R; Verdiani S; Cambiaggi A; Romeo PH; Ferrini S; Moretta L
Eur J Immunol; 1993 May; 23(5):1083-7. PubMed ID: 8386664
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
Siu LL; Wong KF; Chan JK; Kwong YL
Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
[TBL] [Abstract][Full Text] [Related]
14. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
Maeda M; Shadeo A; MacFadyen AM; Takei F
J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) activity of cultured S100 beta-positive T-leukemia cells.
Takahashi K; Yoshino T; Akagi T; Miyatani K; Hayashi K; Sonobe H; Ohtsuki Y
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):159-64. PubMed ID: 1980762
[TBL] [Abstract][Full Text] [Related]
16. Absolute requirement for the pre-T cell receptor alpha chain during NK1.1+ TCRalphabeta cell development.
Eberl G; Fehling HJ; von Boehmer H; MacDonald HR
Eur J Immunol; 1999 Jun; 29(6):1966-71. PubMed ID: 10382759
[TBL] [Abstract][Full Text] [Related]
17. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
18. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Exp Hematol; 2000 Mar; 28(3):276-82. PubMed ID: 10720692
[TBL] [Abstract][Full Text] [Related]
20. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
